Certified by Founder
Lodge
AAVantgarde Bio
start up
Italy
- Milan, Lombardy
- 07/06/2023
- Series A
- $65,333,745
Delivering the next generation gene therapies
- Industry Biotechnology Research
- Website https://www.aavantgardebio.com/
- LinkedIn https://www.linkedin.com/company/aavantgarde-bio/
Related People
Natalia Misciattelli Mocenigo SoranzoFounder
United Kingdom -
Victoria, England
A well-rounded Biotech business executive with a proven track record of delivering shareholder value internationally.
Science and finance background combined with a passion for working in cutting edge technology. Creative thinker with expertise in generating and executing strategies to deliver company growth.
Experienced in building and leading teams through complex growth and transformation whilst managing multiple stakeholder groups in a fast pace evolving landscape. Strong leader skilled at building strategic relationships to drive opportunities and change in organizations.
Iceotope | $26,000,000 | (May 15, 2026)
Harken Sweets | Undisclosed Amount | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Ranger AI | $8,400,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
GridCARE | $64,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)